Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
Date
of
Report (Date of earliest event reported): March
24, 2008
BIOMETRX,
INC.
(Exact
name of registrant as specified in its Charter)
Delaware
|
0-15807
|
31-1190725
|
(State
or other jurisdiction
|
(Commission
|
(IRS
Employer
|
of
incorporation)
|
File
No.)
|
Identification
No.)
|
500
North Broadway, Suite 204, Jericho, New York
|
|
11753
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
(516)
937-2828
(Registrant’s
telephone number, including area code)
N/A
(Former
Name or former address, if changed since last report.)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.24d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.23e-4(c))
Item
1.01
Entry
Into a Material Definitive Agreement
On
March
24, 2008, BioMETRX, Inc. (the “Company”) and Master Lock Company entered into a
letter agreement which amended the Cooperative Development and Marketing
Agreement dated March 26, 2007 (“Original Agreement”) . The letter amends the
Original Agreement to expand the number of products the parties are
co-developing to include an additional nine (9) consumer products.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
|
|
|
BIOMETRX,
INC.
(Registrant)
|
|
|
|
Date:
April 3, 2008 |
By: |
/s/ Mark
Basile |
|
Mark
Basile |
|
Chief
Executive Officer |